{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:25:36Z","timestamp":1788791136594,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd012757","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000}}],"reference-count":118,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012757.pub2","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:27:26Z","timestamp":1723188446000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases"],"prefix":"10.1002","volume":"2024","author":[{"given":"Mateusz J","family":"Swierz","sequence":"additional","affiliation":[{"name":"Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics; Jagiellonian University Medical College; Krakow Poland"},{"name":"2nd Department of General Surgery; Jagiellonian University Medical College; Krakow Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid","family":"Storman","sequence":"additional","affiliation":[{"name":"Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics; Jagiellonian University Medical College; Krakow Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy W","family":"Mitus","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology; The Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch; Department of Anatomy, Jagiellonian University Medical College; Krakow Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Hetnal","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Health Sciences;  Andrzej Frycz Modrzewski Krakow University; Krakow Poland"},{"name":"Radiotherapy Centre Amethyst; Rydygier Memorial Hospital; Krakow Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kukielka","sequence":"additional","affiliation":[{"name":"Center for Oncology Diagnosis and Therapy; NU-MED; Zamosc Poland"},{"name":"Brachytherapy Department; University Hospital; Krakow Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastazja","family":"Szlauer-Stefanska","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation and Oncohematology Department; Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch; Gliwice Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Pedziwiatr","sequence":"additional","affiliation":[{"name":"2nd Department of General Surgery; Jagiellonian University Medical College; Krakow Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wolff","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Kleijnen","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata M","family":"Bala","sequence":"additional","affiliation":[{"name":"Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics; Jagiellonian University Medical College; Krakow Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"issue":"14","key":"10.1002\/14651858.CD012757.pub2-BIB0001|cit1","first-page":"6165","article-title":"Clinical efficacy of transcatheter arterial chemoembolization combined with DC-CIK in the treatment of colorectal cancer with liver metastasis and its effect on the survival of patients","volume":"28","author":"Du","year":"2017","journal-title":"Biomedical Research"},{"issue":"6","key":"10.1002\/14651858.CD012757.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"853.e15","DOI":"10.1016\/j.jvir.2012.04.029","article-title":"Trans arterial hepatic embolization (TACE) adopting polyvinal alcohol microspheres preloaded with irinotecan (DEBIRI) versus systemic therapy (FOLFIRI) for liver metastases (LM) from colorectal cancer (CRC): a randomized study of efficacy, toxicity and quality of life","volume":"23","author":"Fiorentini","year":"2012","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD012757.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/annonc\/mdq521","article-title":"Trans-arterial chemoembolization of metastatic colorectal carcinoma (MCRC) to the liver adopting polyvinyl alcohol microspheres (PAM) loaded with irinotecan compared with FOLFIRI (CT): evaluation at two years of a phase III clinical trial","volume":"21","author":"Fiorentini","year":"2010","journal-title":"Annals of Oncology"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD012757.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/annonc\/mdp282","article-title":"First evaluation of phase III trial of tace adopting polyvinil-alcohol microspheres (PAM) irinotecan (IRI) loaded vs FOLFIRI (CT) for non operable colorectal cancer (CRC) liver metastases","volume":"20","author":"Fiorentini","year":"2009","journal-title":"Annals of Oncology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012757.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/jco.2012.30.4_suppl.587","article-title":"Hepatic arterial embolization adopting polyvinyl alcohol microspheres preloaded with irinotecan versus systemic chemotherapy for hepatic metastases from colorectal cancer: a phase III clinical research trial of activity and quality of life","volume":"30","author":"Fiorentini","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012757.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00270-011-0216-9","article-title":"Evaluation of a phase III clinical trial comparing transarterial chemoembolisation (TACE) using irinotecan-loaded polyvinyl alcohol microsperes (Debiri) vs systemic chemotherapy FOLFIRI (CT) for the treatment of unresectable metastases to the liver (LM) in patients with advanced colorectal cancer (MCRC)","volume":"34","author":"Fiorentini","year":"2011","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"4","key":"10.1002\/14651858.CD012757.pub2-BIB0007|cit7","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Research"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012757.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00270-011-0216-9","article-title":"Trans-arterial chemoembolization of liver metastases from colorectal cancer adopting drug-eluting beads loaded with irinotecan compared with FOLFIRI: results at two years of a phase III clinical trial","volume":"34","author":"Tilli","year":"2011","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3969\/j.issn.2095-1264.2013.009","article-title":"Research on the clinical efficacy of transcatheter arterial chemoembolization in the treatment of multiple liver metastases from colon cancer","volume":"3","author":"Zheng","year":"2013","journal-title":"Anti-Tumor Pharmacy"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0010|cit10","unstructured":"A prospective randomized control study of hepatic metastasis of colonic carcinoma by TACE\/TAC trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR-TRC-14004974"},{"issue":"7","key":"10.1002\/14651858.CD012757.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/bjs.1800770720","article-title":"Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases","volume":"77","author":"Hunt","year":"1990","journal-title":"British Journal of Surgery"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012757.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1245\/s10434-013-3474-8","article-title":"Randomized controlled trial of irinotecan drug eluting beads with simultaneous FOLFOX and bevacizamab for patients with unresectable colorectal liver-limited metastasis","volume":"21","author":"Martin","year":"2014","journal-title":"Annals of Surgical Oncology"},{"issue":"20","key":"10.1002\/14651858.CD012757.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1002\/cncr.29534","article-title":"Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis","volume":"121","author":"Scoggins","year":"2015","journal-title":"Cancer"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD012757.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1200\/jco.2014.32.3_suppl.174","article-title":"Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizamab for patients with unresectable colorectal liver-limited metastasis","volume":"32","author":"Martin","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1245\/s10434-006-9312-5","article-title":"Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study","volume":"14","author":"Ruers","year":"2007","journal-title":"Annals of Surgical Oncology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0016|cit16","unstructured":"TACE with irinotecan drug-eluting beads and intravenous (IV) cetuximab in refractory colorectal cancer (DEBIRITUX) clinicaltrials.gov\/ct2\/show\/NCT01060423"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012757.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00270-011-0216-9","article-title":"A randomized phase II trial of irinotecan drug-eluting beads administered by hepatic chemoembolization with intravenous cetuximab (DEBIRITUX) versus systemic treatment with intravenous cetuximab and irinotecan in patients with refractory colorectal liver metastases and Kras wild-type tumors","volume":"34","author":"Stein","year":"2011","journal-title":"Cardiovascular and Interventional Radiology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0018|cit18","unstructured":"Application and evaluation of drug-eluting beads in interventional therapy of liver metastasis in colorectal cancer trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR1800017919"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.suronc.2017.05.003","article-title":"Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: a systematic review","volume":"26","author":"Akinwande","year":"2017","journal-title":"Surgical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD012757.pub2-BIB0020|cit20","first-page":"4581","article-title":"Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead\u00ae, drug-eluting bead loaded with irinotecan: results of a phase II clinical study","volume":"31","author":"Aliberti","year":"2011","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0021|cit21","unstructured":"ASERNIP-S Review Group A systematic review of radiofrequency ablation for the treatment of liver tumours (update) ASERNIP-S report no. 56 database.inahta.org\/article\/6285"},{"issue":"10","key":"10.1002\/14651858.CD012757.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010163.pub2","article-title":"Microwave coagulation for liver metastases","author":"Bala","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012757.pub2-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010588","article-title":"Transarterial (chemo)embolisation versus other nonsurgical ablation methods for liver metastases","author":"Bala","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012757.pub2-BIB0024|cit24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009058.pub3","article-title":"Cryotherapy for liver metastases","author":"Bala","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012757.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0026|cit26","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive \u2013 Trial Sequential Analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"110","key":"10.1002\/14651858.CD012757.pub2-BIB0029|cit29","first-page":"1","article-title":"Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis","volume":"7","author":"Castellini","year":"2018","journal-title":"Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clinre.2016.05.013","article-title":"Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis","volume":"41","author":"Chen","year":"2017","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD012757.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1586\/14737140.2016.1129277","article-title":"The state of regional therapy in the management of metastatic colorectal cancer to the liver","volume":"16","author":"Cho","year":"2016","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"2","key":"10.1002\/14651858.CD012757.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4254\/wjh.v11.i2.150","article-title":"Colorectal liver metastases: an update on multidisciplinary approach","volume":"11","author":"Chow","year":"2019","journal-title":"World Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012757.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006317.pub3","article-title":"Radiofrequency ablation in the treatment of liver metastases from colorectal cancer","author":"Cirocchi","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0035|cit35","unstructured":"Covidence Veritas Health Innovation 2020"},{"issue":"6","key":"10.1002\/14651858.CD012757.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1245\/s10434-014-4234-0","article-title":"Cure model survival analysis after hepatic resection for colorectal liver metastases","volume":"22","author":"Cucchetti","year":"2015","journal-title":"Annals of Surgical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012757.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1245\/s10434-010-1409-1","article-title":"Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases","volume":"18","author":"D'Angelica","year":"2011","journal-title":"Annals of Surgical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD012757.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40259-018-0322-1","article-title":"Comparative effectiveness and safety of monoclonal antibodies (bevacizumab, cetuximab, and panitumumab) in combination with chemotherapy for metastatic colorectal cancer: a systematic review and meta-analysis","volume":"32","author":"da Silva","year":"2018","journal-title":"BioDrugs"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00270-015-1208-y","article-title":"Treatment of liver tumors with lipiodol TACE: technical recommendations from experts opinion","volume":"39","author":"Baere","year":"2016","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"34","key":"10.1002\/14651858.CD012757.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"55368","DOI":"10.18632\/oncotarget.10552","article-title":"Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients","volume":"7","author":"Ridder","year":"2016","journal-title":"Oncotarget"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0041|cit41","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"11","key":"10.1002\/14651858.CD012757.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.diii.2015.06.017","article-title":"Biliary complications of arterial chemoembolization of hepatocellular carcinoma","volume":"96","author":"Dhamija","year":"2015","journal-title":"Diagnostic and Interventional Imaging"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"7109","key":"10.1002\/14651858.CD012757.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"8","key":"10.1002\/14651858.CD012757.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Cutsem","year":"2016","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012757.pub2-BIB0047|cit47","first-page":"575","article-title":"Chemoembolization in colorectal liver metastases: the rebirth","volume":"34","author":"Fiorentini","year":"2014","journal-title":"Anticancer Research"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"HEP16","DOI":"10.2217\/hep-2019-0010","article-title":"Updates of colorectal cancer liver metastases therapy: review on DEBIRI","volume":"7","author":"Fiorentini","year":"2020","journal-title":"Hepatic Oncology"},{"issue":"9","key":"10.1002\/14651858.CD012757.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jvir.2017.04.025","article-title":"Quality improvement guidelines for transarterial chemoembolization and embolization of hepatic malignancy","volume":"28","author":"Gaba","year":"2017","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"6","key":"10.1002\/14651858.CD012757.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jclinepi.2018.10.009","article-title":"Increased risks for random errors are common in outcomes graded as high certainty of evidence","volume":"106","author":"Gartlehner","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012757.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0053|cit53","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2023"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2307\/2530643","article-title":"Estimation of a common effect parameter from sparse follow-up data","volume":"41","author":"Greenland","year":"1985","journal-title":"Biometrics"},{"issue":"4","key":"10.1002\/14651858.CD012757.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction \u2013 GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12094-018-02002-w","article-title":"SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)","volume":"21","author":"G\u00f3mez-Espa\u00f1a","year":"2019","journal-title":"Clinical & Translational Oncology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0057|cit57","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0058|cit58","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0059|cit59","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0060|cit60","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"5","key":"10.1002\/14651858.CD012757.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jamcollsurg.2009.12.040","article-title":"Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution","volume":"210","author":"House","year":"2010","journal-title":"Journal of the American College of Surgeons"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.ijrobp.2011.07.020","article-title":"Radiotherapy for liver metastases: a review of evidence","volume":"82","author":"H\u00f8yer","year":"2012","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0063|cit63","unstructured":"International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH) ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2) database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"12","key":"10.1002\/14651858.CD012757.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.3390\/cancers12123545","article-title":"Multimodal treatment in metastatic colorectal cancer (mCRC) improves outcomes \u2013 the University College London Hospital (UCLH) experience","volume":"12","author":"Joharatnam-Hogan","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1002\/14651858.CD012757.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/bjs.8667","article-title":"Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases","volume":"99","author":"Jones","year":"2012","journal-title":"British Journal of Surgery"},{"issue":"12","key":"10.1002\/14651858.CD012757.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.ejso.2016.07.142","article-title":"PARAGON II \u2013 a single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer","volume":"42","author":"Jones","year":"2016","journal-title":"European Journal of Surgical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"169","DOI":"10.14218\/JCTH.2015.00012","article-title":"Hepatobiliary tumors: update on diagnosis and management","volume":"3","author":"Kabbach","year":"2015","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/jcm8030403","article-title":"Treatment of liver metastases from midgut neuroendocrine tumours: a systematic review and meta-analysis","volume":"8","author":"Kacmaz","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/CLEP.S34285","article-title":"Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors","volume":"4","author":"Kanas","year":"2012","journal-title":"Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD012757.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/cancers13061371","article-title":"Review of intra-arterial therapies for colorectal cancer liver metastasis","volume":"13","author":"Kwan","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/SLA.0000000000001624","article-title":"Colorectal cancer liver metastases and concurrent extrahepatic disease treated with resection","volume":"265","author":"Leung","year":"2017","journal-title":"Annals of Surgery"},{"issue":"10","key":"10.1002\/14651858.CD012757.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.hpb.2018.04.001","article-title":"Intra-arterial therapies for unresectable and chemorefractory colorectal cancer liver metastases: a systematic review and meta-analysis","volume":"20","author":"Levy","year":"2018","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1002\/14651858.CD012757.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012757.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.crad.2017.05.016","article-title":"The management of colorectal liver metastases","volume":"72","author":"Maher","year":"2017","journal-title":"Clinical Radiology"},{"issue":"4","key":"10.1002\/14651858.CD012757.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jnci\/22.4.719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"issue":"10","key":"10.1002\/14651858.CD012757.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"761","DOI":"10.5306\/wjco.v11.i10.761","article-title":"Colorectal liver metastases: current management and future perspectives","volume":"11","author":"Martin","year":"2020","journal-title":"World Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"e3940","DOI":"10.7759\/cureus.3940","article-title":"Literature review of current management of colorectal liver metastasis","volume":"11","author":"Mitchell","year":"2019","journal-title":"Cureus"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007823.pub2","article-title":"Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer","author":"Mocellin","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012757.pub2-BIB0080|cit80","first-page":"2077","article-title":"Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer","volume":"33","author":"Narayanan","year":"2013","journal-title":"Anticancer Research"},{"issue":"7","key":"10.1002\/14651858.CD012757.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s12094-015-1277-z","article-title":"Effectiveness of surgery in liver metastasis from colorectal cancer: experience and results of a continuous improvement process","volume":"17","author":"Navarro-Freire","year":"2015","journal-title":"Clinical and Translational Oncology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0082|cit82","unstructured":"NCCN Guidelines \u2013 treatment by cancer type www.nccn.org\/guidelines\/category_1"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0083|cit83","unstructured":"National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 Available from www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf 2009"},{"issue":"2","key":"10.1002\/14651858.CD012757.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0269216307087659","article-title":"The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991\u20132006)","volume":"22","author":"Nekolaichuk","year":"2008","journal-title":"Palliative Medicine"},{"issue":"12","key":"10.1002\/14651858.CD012757.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0087|cit87","first-page":"n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/ajco.12438","article-title":"Hepatic artery embolization in advanced neuroendocrine tumors: efficacy and long-term outcomes","volume":"12","author":"Pericleous","year":"2016","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012757.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41416-020-0917-4","article-title":"Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study","volume":"123","author":"Pernot","year":"2020","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0091|cit91","unstructured":"Peryer G Golder S Junqueira D Vohra S Loke YK Chapter 19: Adverse effects. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"12","key":"10.1002\/14651858.CD012757.pub2-BIB0092|cit92","first-page":"5159","article-title":"Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumors of the liver","volume":"30","author":"Poggi","year":"2010","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0093|cit93","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3332\/ecancer.2015.582","article-title":"Effectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysis","volume":"9","author":"Rosa","year":"2015","journal-title":"Ecancermedicalscience"},{"issue":"6","key":"10.1002\/14651858.CD012757.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012757.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES Meta-Epidemiologic Study","volume":"187","author":"Savovic","year":"2018","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0097|cit97","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009497.pub3","article-title":"Electrocoagulation for liver metastases","author":"Storman","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012757.pub2-BIB0100|cit100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008717.pub3","article-title":"Percutaneous ethanol injection for liver metastases","author":"Swierz","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009498.pub4","article-title":"Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases","author":"Swierz","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0103|cit103","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0104|cit104","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User Manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017 Available from ctu.dk\/tsa\/learn-more"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0106|cit106","unstructured":"TSA \u2013 Trial Sequential Analysis Copenhagen Trial Unit 2021"},{"issue":"41","key":"10.1002\/14651858.CD012757.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"11767","DOI":"10.3748\/wjg.v21.i41.11767","article-title":"Colorectal cancer: metastases to a single organ","volume":"21","author":"Vatandoust","year":"2015","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012757.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00330-006-0372-5","article-title":"Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update","volume":"17","author":"Vogl","year":"2007","journal-title":"European Radiology"},{"issue":"6","key":"10.1002\/14651858.CD012757.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/cancers14061503","article-title":"The role of conventional TACE (cTACE) and DEBIRI-TACE in colorectal cancer liver metastases","volume":"14","author":"Vogl","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1002\/14651858.CD012757.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02575467","article-title":"Hepatic artery infusion and chemoembolization in the management of liver metastases","volume":"13","author":"Wallace","year":"1990","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD012757.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12957-018-1368-8","article-title":"CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study","volume":"16","author":"Wu","year":"2018","journal-title":"World Journal of Surgical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD012757.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11864-018-0597-y","article-title":"Capecitabine versus continuous infusion fluorouracil for the treatment of advanced or metastatic colorectal cancer: a meta-analysis","volume":"19","author":"Wu","year":"2018","journal-title":"Current Treatment Options in Oncology"},{"issue":"10","key":"10.1002\/14651858.CD012757.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"e0139940","DOI":"10.1371\/journal.pone.0139940","article-title":"Comparative effectiveness of hepatic artery based therapies for unresectable colorectal liver metastases: a meta-analysis","volume":"10","author":"Zacharias","year":"2015","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD012757.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD012757.pub2-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012757","article-title":"Transarterial (chemo)embolisation versus chemotherapy for colorectal cancer liver metastases","author":"Bala","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T09:30:03Z","timestamp":1763458203000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012757.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":118,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012757.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]}}}